Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)

Clinical trial NCT03946358 · COMPLETED

Trial details

NCT number: NCT03946358
Sponsor: Centre Hospitalier Universitaire de Besancon
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck Anal Canal Cancer Cervical Cancer

Start date: 2020-02-18
Primary completion: 2024-03-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.